You're missing all of the big elephants in the room mate. I'm...

First 91 Last

Share
Profile

Follow
PharmD

1,061 Posts.

219

02/09/24

19:09

Post #: 75494495
Share

Originally posted by slasha: ↑

"Slasha I keep pointing out that the fact of the matter is they only closed the gap to profitability by 60k over the last financial year. Have you read the report? Have you had a look how many 1,000,000s are required to close the gap? Hint: it's a lot."

Ah no, I've just invested enough to hit the top 10 and have no idea lol.

I believe the roughly 1.6m in reality, not the 1.8, (given we received from the payment), will see the GAP of say roughly 1.4 - 1.5 will be closed out this quarter, you obviously don't agree and that's fine, as you are not looking to invest non of this will effect you good or bad.

I have put my money weher my mouth is, so let's see.

"It's a lot especially when Limepay's costs are going to jump onboard and so are new staff members not including those coming from Lime-pay. They are also on a HR drive due possibly to poor staff retention. How do you not see this? No deal in the past has ever quickly added a decent amount of revenue to cause such a massive jump."

Are you winding me up, or are you not seriously able to read my post?

Imagine buying a dud like lime-pay and as a team securing a deal, (before we are even officially a team), that Lessn current payments $50m which will produce revenue for Limepay/ Spenda of $1m so 2%.Lessn aiming for payments of $2.4bn within 2 years, let’s say 1% of that is $24 million per year.

8m for this, the team, their books and now the competition being even further away from ever catching up.

This will have already started to grow rapidly IMO, as stated in this article already looking to expand into Singapore, updates expected shortly.

How's that RB, you get it this time?

Expand

You're missing all of the big elephants in the room mate. I'm trying my best to help you out.

SPX Price at posting: 0.9¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 103 more messages in this thread...

First 91 Last

Add SPX (ASX) to my watchlist

(20min delay)
Last 1.2¢		Change 0.001(9.09%)		Mkt cap ! $55.24M

Open	High	Low	Value	Volume
1.0¢	1.2¢	1.0¢	$24.26K	2.227M

Buyers (Bids)

No.	Vol.	Price($)
1	22503	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	12324492	15

View Market Depth

No.	Vol.	Price($)
1	22503	0.011
13	5209630	0.010
15	5850838	0.009
11	6858248	0.008
5	5732562	0.007

Price($)	Vol.	No.
0.012	12324492	15
0.013	9292645	11
0.014	8465378	14
0.015	7363083	7
0.016	5000000	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

SPX (ASX) Chart

You're missing all of the big elephants in the room mate. I'm...

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You're missing all of the big elephants in the room mate. I'm...

Top Stories

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News